Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Taphoorn MJ"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-16 z 16
    Tytuł:
    Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
    Autorzy:
    Maringwa JT
    Quinten C
    King M
    Ringash J
    Osoba D
    Coens C
    Martinelli F
    Vercauteren J
    Cleeland CS
    Flechtner H
    Gotay C
    Greimel E
    Taphoorn MJ
    Reeve BB
    Koch JS
    Weis J
    Smit EF
    van Meerbeeck JP
    Bottomley A
    EORTC PROBE project and the Lung Cancer Group
    Pokaż więcej
    Źródło:
    Supportive Care in Cancer; Nov2011, Vol. 19 Issue 11, p1753-1760, 8p
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Bandolier's little book of pain.
    Autorzy:
    Taphoorn MJ
    Pokaż więcej
    Źródło:
    European Journal of Cancer Care; Sep2004, Vol. 13 Issue 4, p393-393, 1p
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Development of an item bank for computerized adaptive testing of self-reported cognitive difficulty in cancer patients.
    Autorzy:
    Dirven L; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
    Taphoorn MJ; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
    Groenvold M; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
    Habets EJ; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
    Aaronson NK; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
    Conroy T; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
    Reijneveld JC; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
    Young T; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
    Petersen MA; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
    Pokaż więcej
    Corporate Authors:
    EORTC Quality of Life Group
    Źródło:
    Neuro-oncology practice [Neurooncol Pract] 2017 Sep; Vol. 4 (3), pp. 189-196. Date of Electronic Publication: 2017 Jan 19.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.
    Autorzy:
    Ediebah DE; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
    Reijneveld JC; Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.
    Taphoorn MJ; Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.; Department of Neurology, Medical Center Haaglanden, The Hague, The Netherlands.
    Coens C; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
    Zikos E; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
    Aaronson NK; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Heimans JJ; Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.
    Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
    Klein M; Department of Medical Psychology - B7D349, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands. .
    Pokaż więcej
    Corporate Authors:
    EORTC Quality of Life Department and Patient Reported Outcome and Behavioral Evidence (PROBE)
    Źródło:
    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2017 Apr; Vol. 26 (4), pp. 869-880. Date of Electronic Publication: 2016 Oct 15.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Quality of Life*
    Brain Neoplasms/*complications
    Cognitive Dysfunction/*psychology
    Glioma/*complications
    Adult ; Brain Neoplasms/pathology ; Cognitive Dysfunction/complications ; Cross-Sectional Studies ; Data Interpretation, Statistical ; Female ; Glioma/pathology ; Humans ; Male ; Neoplasm Grading ; Netherlands ; Proxy ; Self Report
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Advance Care Planning in Glioblastoma Patients.
    Autorzy:
    Fritz L; Department of Neurology, Haaglanden Medical Center, P.O. BOX 432, 2501 CK The Hague, The Netherlands. .
    Dirven L; Department of Neurology, Leiden University Medical Center, P.O. BOX 9600, 2300 RC Leiden, The Netherlands. .
    Reijneveld JC; Department of Neurology, VU University Medical Center, P.O. BOX 7057, 1007 MB Amsterdam, The Netherlands. .; Department of Neurology, Academic Medical Center, P.O. BOX 22660, 1100 DD Amsterdam, The Netherlands. .
    Koekkoek JA; Department of Neurology, Haaglanden Medical Center, P.O. BOX 432, 2501 CK The Hague, The Netherlands. .; Department of Neurology, Leiden University Medical Center, P.O. BOX 9600, 2300 RC Leiden, The Netherlands. .
    Stiggelbout AM; Department of Medical Decision Making/Quality of Care, Leiden University Medical Center, P.O. BOX 9600, 2300 RC Leiden, The Netherlands. .
    Pasman HR; Department of Public and Occupational Health, VU University Medical Center, P.O. BOX 7057, 1007 MB Amsterdam, The Netherlands. .
    Taphoorn MJ; Department of Neurology, Haaglanden Medical Center, P.O. BOX 432, 2501 CK The Hague, The Netherlands. m.j.b.taphoorn@lumc.nl.; Department of Neurology, Leiden University Medical Center, P.O. BOX 9600, 2300 RC Leiden, The Netherlands. m.j.b.taphoorn@lumc.nl.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2016 Nov 08; Vol. 8 (11). Date of Electronic Publication: 2016 Nov 08.
    Typ publikacji:
    Review; Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Joint modeling of longitudinal health-related quality of life data and survival.
    Autorzy:
    Ediebah DE; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium, .
    Galindo-Garre F
    Uitdehaag BM
    Ringash J
    Reijneveld JC
    Dirven L
    Zikos E
    Coens C
    van den Bent MJ
    Bottomley A
    Taphoorn MJ
    Pokaż więcej
    Źródło:
    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2015 Apr; Vol. 24 (4), pp. 795-804. Date of Electronic Publication: 2014 Oct 14.
    Typ publikacji:
    Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Outcome Assessment, Health Care*
    Quality of Life*
    Brain Neoplasms/*mortality
    Oligodendroglioma/*mortality
    Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Brain Neoplasms/drug therapy ; Brain Neoplasms/radiotherapy ; Female ; Humans ; Lomustine/therapeutic use ; Male ; Middle Aged ; Models, Statistical ; Oligodendroglioma/drug therapy ; Oligodendroglioma/radiotherapy ; Procarbazine/therapeutic use ; Surveys and Questionnaires ; Time ; Treatment Outcome ; Vincristine/therapeutic use ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Health-related quality of life and other clinical outcome assessments in brain tumor patients: challenges in the design, conduct and interpretation of clinical trials.
    Autorzy:
    Dirven L; VU University Medical Center, Department of Neurology , Amsterdam , Netherlands (L.D., M.J.B.T.); The University of Texas Health Science Center at Houston, School of Nursing, Department of Family Health , Houston, Texas (T.S.A.); The University of Texas M.D. Anderson Cancer Center, Department of Neuro-Oncology, Houston, Texas (T.S.A.); Medical Center Haaglanden, Department of Neurology, The Hague , Netherlands (M.J.B.T.).
    Armstrong TS; VU University Medical Center, Department of Neurology , Amsterdam , Netherlands (L.D., M.J.B.T.); The University of Texas Health Science Center at Houston, School of Nursing, Department of Family Health , Houston, Texas (T.S.A.); The University of Texas M.D. Anderson Cancer Center, Department of Neuro-Oncology, Houston, Texas (T.S.A.); Medical Center Haaglanden, Department of Neurology, The Hague , Netherlands (M.J.B.T.).
    Taphoorn MJ; VU University Medical Center, Department of Neurology , Amsterdam , Netherlands (L.D., M.J.B.T.); The University of Texas Health Science Center at Houston, School of Nursing, Department of Family Health , Houston, Texas (T.S.A.); The University of Texas M.D. Anderson Cancer Center, Department of Neuro-Oncology, Houston, Texas (T.S.A.); Medical Center Haaglanden, Department of Neurology, The Hague , Netherlands (M.J.B.T.).
    Pokaż więcej
    Źródło:
    Neuro-oncology practice [Neurooncol Pract] 2015 Mar; Vol. 2 (1), pp. 2-5.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma.
    Autorzy:
    Gehring K; Tilburg University, Department of Cognitive Neuropsychology , Tilburg , The Netherlands (K.G., M.M.S.); Medical Center Haaglanden, Department of Neurology , The Hague , The Netherlands (M.J.B.T.); VU University Medical Center, Department of Neurology , Amsterdam, The Netherlands (M.J.B.T.); The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology , Amsterdam , The Netherlands (N.K.A.); Programme Group Clinical Psychology , University of Amsterdam , Amsterdam , The Netherlands (N.K.A.).
    Taphoorn MJ; Tilburg University, Department of Cognitive Neuropsychology , Tilburg , The Netherlands (K.G., M.M.S.); Medical Center Haaglanden, Department of Neurology , The Hague , The Netherlands (M.J.B.T.); VU University Medical Center, Department of Neurology , Amsterdam, The Netherlands (M.J.B.T.); The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology , Amsterdam , The Netherlands (N.K.A.); Programme Group Clinical Psychology , University of Amsterdam , Amsterdam , The Netherlands (N.K.A.).
    Sitskoorn MM; Tilburg University, Department of Cognitive Neuropsychology , Tilburg , The Netherlands (K.G., M.M.S.); Medical Center Haaglanden, Department of Neurology , The Hague , The Netherlands (M.J.B.T.); VU University Medical Center, Department of Neurology , Amsterdam, The Netherlands (M.J.B.T.); The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology , Amsterdam , The Netherlands (N.K.A.); Programme Group Clinical Psychology , University of Amsterdam , Amsterdam , The Netherlands (N.K.A.).
    Aaronson NK; Tilburg University, Department of Cognitive Neuropsychology , Tilburg , The Netherlands (K.G., M.M.S.); Medical Center Haaglanden, Department of Neurology , The Hague , The Netherlands (M.J.B.T.); VU University Medical Center, Department of Neurology , Amsterdam, The Netherlands (M.J.B.T.); The Netherlands Cancer Institute, Division of Psychosocial Research and Epidemiology , Amsterdam , The Netherlands (N.K.A.); Programme Group Clinical Psychology , University of Amsterdam , Amsterdam , The Netherlands (N.K.A.).
    Pokaż więcej
    Źródło:
    Neuro-oncology practice [Neurooncol Pract] 2015 Mar; Vol. 2 (1), pp. 20-31. Date of Electronic Publication: 2015 Mar 03.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study.
    Autorzy:
    Koekkoek JA
    Kerkhof M
    Dirven L
    Heimans JJ
    Postma TJ
    Vos MJ
    Bromberg JE
    van den Bent MJ
    Reijneveld JC
    Taphoorn MJ
    Pokaż więcej
    Źródło:
    BMC neurology [BMC Neurol] 2014 Aug 15; Vol. 14, pp. 157. Date of Electronic Publication: 2014 Aug 15.
    Typ publikacji:
    Journal Article; Observational Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anticonvulsants/*administration & dosage
    Brain Neoplasms/*complications
    Glioma/*complications
    Seizures/*drug therapy
    Seizures/*etiology
    Humans ; Prospective Studies ; Research Design
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    The association between cognitive functioning and health-related quality of life in low-grade glioma patients.
    Autorzy:
    Boele FW; Department of Medical Psychology , VU University Medical Center , Amsterdam, the Netherlands (F.W.B., M.Z., E.C.E.H., M.K.); Department of Neurology , VU University Medical Center , Amsterdam, the Netherlands (J.J.H., T.J.P., J.C.R.); Department of Neurology , Medical Center Haaglanden , The Hague, the Netherlands (M.J.B.T.); Division of Psychosocial Research and Epidemiology , The Netherlands Cancer Institute , Amsterdam , the Netherlands (N.K.A.).
    Zant M; Department of Medical Psychology , VU University Medical Center , Amsterdam, the Netherlands (F.W.B., M.Z., E.C.E.H., M.K.); Department of Neurology , VU University Medical Center , Amsterdam, the Netherlands (J.J.H., T.J.P., J.C.R.); Department of Neurology , Medical Center Haaglanden , The Hague, the Netherlands (M.J.B.T.); Division of Psychosocial Research and Epidemiology , The Netherlands Cancer Institute , Amsterdam , the Netherlands (N.K.A.).
    Heine EC; Department of Medical Psychology , VU University Medical Center , Amsterdam, the Netherlands (F.W.B., M.Z., E.C.E.H., M.K.); Department of Neurology , VU University Medical Center , Amsterdam, the Netherlands (J.J.H., T.J.P., J.C.R.); Department of Neurology , Medical Center Haaglanden , The Hague, the Netherlands (M.J.B.T.); Division of Psychosocial Research and Epidemiology , The Netherlands Cancer Institute , Amsterdam , the Netherlands (N.K.A.).
    Aaronson NK; Department of Medical Psychology , VU University Medical Center , Amsterdam, the Netherlands (F.W.B., M.Z., E.C.E.H., M.K.); Department of Neurology , VU University Medical Center , Amsterdam, the Netherlands (J.J.H., T.J.P., J.C.R.); Department of Neurology , Medical Center Haaglanden , The Hague, the Netherlands (M.J.B.T.); Division of Psychosocial Research and Epidemiology , The Netherlands Cancer Institute , Amsterdam , the Netherlands (N.K.A.).
    Taphoorn MJ; Department of Medical Psychology , VU University Medical Center , Amsterdam, the Netherlands (F.W.B., M.Z., E.C.E.H., M.K.); Department of Neurology , VU University Medical Center , Amsterdam, the Netherlands (J.J.H., T.J.P., J.C.R.); Department of Neurology , Medical Center Haaglanden , The Hague, the Netherlands (M.J.B.T.); Division of Psychosocial Research and Epidemiology , The Netherlands Cancer Institute , Amsterdam , the Netherlands (N.K.A.).
    Reijneveld JC; Department of Medical Psychology , VU University Medical Center , Amsterdam, the Netherlands (F.W.B., M.Z., E.C.E.H., M.K.); Department of Neurology , VU University Medical Center , Amsterdam, the Netherlands (J.J.H., T.J.P., J.C.R.); Department of Neurology , Medical Center Haaglanden , The Hague, the Netherlands (M.J.B.T.); Division of Psychosocial Research and Epidemiology , The Netherlands Cancer Institute , Amsterdam , the Netherlands (N.K.A.).
    Postma TJ; Department of Medical Psychology , VU University Medical Center , Amsterdam, the Netherlands (F.W.B., M.Z., E.C.E.H., M.K.); Department of Neurology , VU University Medical Center , Amsterdam, the Netherlands (J.J.H., T.J.P., J.C.R.); Department of Neurology , Medical Center Haaglanden , The Hague, the Netherlands (M.J.B.T.); Division of Psychosocial Research and Epidemiology , The Netherlands Cancer Institute , Amsterdam , the Netherlands (N.K.A.).
    Heimans JJ; Department of Medical Psychology , VU University Medical Center , Amsterdam, the Netherlands (F.W.B., M.Z., E.C.E.H., M.K.); Department of Neurology , VU University Medical Center , Amsterdam, the Netherlands (J.J.H., T.J.P., J.C.R.); Department of Neurology , Medical Center Haaglanden , The Hague, the Netherlands (M.J.B.T.); Division of Psychosocial Research and Epidemiology , The Netherlands Cancer Institute , Amsterdam , the Netherlands (N.K.A.).
    Klein M; Department of Medical Psychology , VU University Medical Center , Amsterdam, the Netherlands (F.W.B., M.Z., E.C.E.H., M.K.); Department of Neurology , VU University Medical Center , Amsterdam, the Netherlands (J.J.H., T.J.P., J.C.R.); Department of Neurology , Medical Center Haaglanden , The Hague, the Netherlands (M.J.B.T.); Division of Psychosocial Research and Epidemiology , The Netherlands Cancer Institute , Amsterdam , the Netherlands (N.K.A.).
    Pokaż więcej
    Źródło:
    Neuro-oncology practice [Neurooncol Pract] 2014 Jun; Vol. 1 (2), pp. 40-46. Date of Electronic Publication: 2014 May 06.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.
    Autorzy:
    Ediebah DE; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Avenue Mounier, 83 b11, 1200 Brussels, Belgium.
    Coens C; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Avenue Mounier, 83 b11, 1200 Brussels, Belgium.
    Zikos E; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Avenue Mounier, 83 b11, 1200 Brussels, Belgium.
    Quinten C; 1] Quality of Life Department, European Organisation for Research and Treatment of Cancer, Avenue Mounier, 83 b11, 1200 Brussels, Belgium [2] Department of Biostatistics, European Centre for Disease Prevention and Control, Surveillance and Response Support Unit, Tomtebodavägen 11a, 171 83 Stockholm, Sweden.
    Ringash J; Department of Radiation Oncology, The Princess Margaret Hospital and the University of Toronto, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9.
    King MT; Department of Psychology, Psycho-oncology Co-operative Research Group (PoCoG), The University of Sydney, Sydney, New South Wales NSW 2006, Australia.
    Schmucker von Koch J; Department of Ethics, University of Regensburg, Medical Ethics, Universitaetsstrasse 31, D-93040 Regensburg, Germany.
    Gotay C; School of Population and Public Health, University of British Columbia, Room 162-2206 East Mall, Vancouver, British Columbia, Canada BC V6T 1Z3.
    Greimel E; Department of Obstetrics and Gynecology, Medical University Graz, Auenbruggerplatz 14, AT 8036 Graz, Austria.
    Flechtner H; Department of Child and Adolescent Psychiatry, University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany.
    Weis J; Psychosocial Department, Tumor Biology Center at the University of Freiburg, Breisacher Str. 117, 79106 Freiburg, Germany.
    Reeve BB; Department of Health Policy and Management, University of North Carolina at Chapel Hill, 1101-D McGavran-Greenberg Building Chapel Hill, Chapel Hill, NC 27599, USA.
    Smit EF; Department of Pulmonology, VU University Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands.
    Taphoorn MJ; Department of Neurology, VU University Medical Center/Medical Center Haaglanden 2501 CK, The Hague, The Netherlands.
    Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Avenue Mounier, 83 b11, 1200 Brussels, Belgium.
    Pokaż więcej
    Źródło:
    British journal of cancer [Br J Cancer] 2014 May 13; Vol. 110 (10), pp. 2427-33. Date of Electronic Publication: 2014 Apr 17.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Quality of Life*
    Carcinoma, Non-Small-Cell Lung/*mortality
    Lung Neoplasms/*mortality
    Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/psychology ; Cisplatin/administration & dosage ; Clinical Trials, Phase III as Topic/statistics & numerical data ; Deglutition Disorders/epidemiology ; Deglutition Disorders/etiology ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Humans ; Interpersonal Relations ; Lung Neoplasms/drug therapy ; Lung Neoplasms/psychology ; Multicenter Studies as Topic/statistics & numerical data ; Nausea/epidemiology ; Nausea/etiology ; Paclitaxel/administration & dosage ; Pain/epidemiology ; Pain/etiology ; Palliative Care ; Prognosis ; Proportional Hazards Models ; Randomized Controlled Trials as Topic/statistics & numerical data ; Risk ; Severity of Illness Index ; Surveys and Questionnaires ; Survival Analysis ; Gemcitabine
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group study.
    Autorzy:
    Mauer M; European Organisation for Research and Treatment of Cancer, Quality of Life Unit, Data Center, Avenue Mounier 83/11, 1200 Brussels, Belgium. />Stupp R
    Taphoorn MJ
    Coens C
    Osoba D
    Marosi C
    Wong R
    de Witte O
    Cairncross JG
    Efficace F
    Mirimanoff RO
    Forsyth P
    van den Bent MJ
    Weller M
    Bottomley A
    Pokaż więcej
    Źródło:
    British journal of cancer [Br J Cancer] 2007 Aug 06; Vol. 97 (3), pp. 302-7. Date of Electronic Publication: 2007 Jul 03.
    Typ publikacji:
    Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Quality of Life*
    Survival Analysis*
    Brain Neoplasms/*physiopathology
    Glioblastoma/*physiopathology
    Female ; Humans ; Male ; Middle Aged ; Prognosis ; Prospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Angiostatin prolongs the survival of mice with leptomeningeal metastases.
    Autorzy:
    Reijneveld JC; Department of Neurology, University Medical Center, 3508 GA Utrecht, the Netherlands.
    Taphoorn MJ
    Kerckhaert OA
    Drixler TA
    Boogerd W
    Voest EE
    Pokaż więcej
    Źródło:
    European journal of clinical investigation [Eur J Clin Invest] 2003 Jan; Vol. 33 (1), pp. 76-81.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Angiogenesis Inhibitors/*therapeutic use
    Antineoplastic Agents/*therapeutic use
    Meningeal Neoplasms/*drug therapy
    Meningeal Neoplasms/*secondary
    Peptide Fragments/*therapeutic use
    Plasminogen/*therapeutic use
    Angiostatins ; Animals ; Humans ; Male ; Melanoma/blood supply ; Melanoma/drug therapy ; Melanoma/secondary ; Meningeal Neoplasms/blood supply ; Mice ; Mice, Inbred BALB C ; Neoplasm Transplantation ; Neovascularization, Pathologic/drug therapy ; Neovascularization, Pathologic/pathology ; Survival Rate
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.
    Autorzy:
    Klein M; Department of Medical Psychology, Vrije Universiteit Medical Centre, Amsterdam, The Netherlands. />Heimans JJ
    Aaronson NK
    van der Ploeg HM
    Grit J
    Muller M
    Postma TJ
    Mooij JJ
    Boerman RH
    Beute GN
    Ossenkoppele GJ
    van Imhoff GW
    Dekker AW
    Jolles J
    Slotman BJ
    Struikmans H
    Taphoorn MJ
    Pokaż więcej
    Źródło:
    Lancet (London, England) [Lancet] 2002 Nov 02; Vol. 360 (9343), pp. 1361-8.
    Typ publikacji:
    Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Brain/*radiation effects
    Cognition Disorders/*etiology
    Glioma/*radiotherapy
    Psychomotor Performance/*radiation effects
    Radiation Injuries/*physiopathology
    Adult ; Case-Control Studies ; Dose-Response Relationship, Radiation ; Female ; Glioma/classification ; Glioma/pathology ; Humans ; Male ; Middle Aged ; Netherlands ; Neuropsychological Tests ; Time Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A novel germline mutation of PTEN associated with brain tumours of multiple lineages.
    Autorzy:
    Staal FJ; Department of Immunology, Erasmus University Rotterdam, Rotterdam, The Netherlands. />van der Luijt RB
    Baert MR
    van Drunen J
    van Bakel H
    Peters E
    de Valk I
    van Amstel HK
    Taphoorn MJ
    Jansen GH
    van Veelen CW
    Burgering B
    Staal GE
    Pokaż więcej
    Źródło:
    British journal of cancer [Br J Cancer] 2002 May 20; Vol. 86 (10), pp. 1586-91.
    Typ publikacji:
    Case Reports; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Amino Acid Substitution*
    Frontal Lobe*/pathology
    Germ-Line Mutation*
    Mutation, Missense*
    Point Mutation*
    Protein Serine-Threonine Kinases*
    Brain Neoplasms/*genetics
    Meningeal Neoplasms/*genetics
    Meningioma/*genetics
    Neoplasm Proteins/*genetics
    Neoplasms, Multiple Primary/*genetics
    Oligodendroglioma/*genetics
    Phosphoric Monoester Hydrolases/*genetics
    Tumor Suppressor Proteins/*genetics
    Adult ; Apoptosis/genetics ; Brain Neoplasms/pathology ; Cell Division ; Cell Lineage ; DNA Mutational Analysis ; DNA, Neoplasm/genetics ; Enzyme Activation/drug effects ; Genetic Predisposition to Disease ; Humans ; Insulin/pharmacology ; Loss of Heterozygosity ; Male ; Meningeal Neoplasms/pathology ; Meningioma/pathology ; Models, Molecular ; Neoplasm Proteins/chemistry ; Neoplasm Proteins/physiology ; Neoplasms, Multiple Primary/pathology ; Oligodendroglioma/pathology ; PTEN Phosphohydrolase ; Phosphoric Monoester Hydrolases/chemistry ; Phosphoric Monoester Hydrolases/physiology ; Protein Conformation ; Proto-Oncogene Proteins/metabolism ; Proto-Oncogene Proteins c-akt ; Transfection ; Tumor Suppressor Proteins/chemistry ; Tumor Suppressor Proteins/physiology ; U937 Cells/drug effects ; U937 Cells/enzymology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-16 z 16

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies